2nd Quarter - Report

VIZIENT, INC. for VIZIENT INC

Firm
Client
Income
—
Expenses
$55,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Not-for-profit hospital tax-exemption - Monitored ongoing efforts from House Ways and Means Committee and Senate Finance Committee related to tax reform. Advocated for maintaining current hospital tax-exemption, exemptions for charitable donations and stable tax-exempt bond financing opportunities for non-profit hospitals. Monitored ongoing implementation efforts of new requirements for tax-exempt hospitals under the Affordable Care Act.

LobbyistCovered position, as disclosed
EDWARD GOODMAN —
CIDETTE PERRIN —

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Internal Revenue Service (IRS); SENATE

Health Issues HCR

340 B drug discount program - Advocated for additional time for hospitals to comply with revised guidance on the GPO exclusion utilized by the program. Hospital group purchasing - Conducted outreach efforts to promote the value offered to hospitals by group purchasing organizations Compounding pharmacies - (S. 959) monitored legislation that would increase regulation on compounding pharmacies.Pharmaceutical supply-chain security and shortages of prescription drugs - (H.R. 1919, S. 957) - Monitored legislative development of House and Senate "Track and Trace" legislation. Unique device identification - Advocated for the release of the final rule implementing a unique device identification system for medical devices.

LobbyistCovered position, as disclosed
EDWARD GOODMAN —
CIDETTE PERRIN —

Contacted: HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Food & Drug Administration (FDA); SENATE; Health Resources & Services Administration (HRSA)

Bills named: S. 959 (113th), H.R. 1919 (113th), S. 957 (113th)

Medicare/Medicaid MMM

Budget Control Act - Advocated for a delay or repeal of Medicare sequestration cuts in the Budget Control Act. Hospital Disproportionate Share Payments - Supported legislation (H.R. 1920) that would delay mandated DSH cuts in the Affordable Care Act. Supported confirmation of Marilyn Tavenner to be Administrator of the Centers for Medicare and Medicaid Services.Sustainable growth rate formula (H.R.574, Senate Finance, House Energy and Commerce and House Ways and Means Committee drafts) - Monitored ongoing discussions to replace the sustainable growth rate formula for Medicare reimbursement for physicians. Advocated against further cuts to hospital payments in order to offset replacement costs.

LobbyistCovered position, as disclosed
EDWARD GOODMAN —
CIDETTE PERRIN —

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Internal Revenue Service (IRS); SENATE

Bills named: H.R. 1920 (113th), H.R. 574 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.